Genzyme Adds Whitworth to Board, WSJ Says
Summary
Genzyme Adds Whitworth to Board, WSJ Says Xconomy Boston — Genzyme (NASDAQ: GENZ), the Cambridge, MA-based biotech giant, has agreed to add Ralph Whitworth, the prominent San Diego activist investor, to its board of directors immediately, according to a report this evening on the Wall Street Journal’s website, which cited a person familiar with the matter.Adding Whitworth could make things more difficult for another activist shareholder, billionaire Carl Icahn, who is calling for significant change at Genzyme in the wake of its manufacturing troubles of the past year.Relational Investors, Whitworth’s firm, has a 4 percent stake in Genzyme.Whitworth reached a “mutual cooperation” agreement with the company in January.A Genzyme spokesman didn’t immediately respond to an e-mailed request for comment late Wednesday night.